v3.26.1
Share-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Expense
The Company recognized share-based compensation in its Condensed Statements of Operations and Comprehensive Loss during the three months ended March 31, 2026 and 2025 as follows:
 Three Months Ended
March 31,
 20262025
Manufacture and supply$69 $100 
Research and development236 330 
Selling, general and administrative2,013 1,157 
Total share-based compensation expenses$2,318 $1,587 
Share-based compensation from:
Restricted stock units$1,655 $1,102 
Stock options663 485 
Total share-based compensation expenses$2,318 $1,587 
Schedule of Restricted Stock Units Awards
The following tables summarize the Company’s awards of service-based and market conditions vesting-based restricted stock units for the three month period ended March 31, 2026:
Restricted Stock Unit Awards (RSUs) - Service-based:Number of
Units		Weighted
Average
Grant Date Fair
Value
 (in thousands) 
Unvested as of December 31, 20252,684 $3.24 
Granted1,282 $4.29 
Vested(1,125)$2.32 
Forfeited(2)$4.14 
Unvested as of March 31, 20262,839 $4.08 
Expected to vest as of March 31, 20262,597 $4.08 
Schedule of Stock Option Activity
Restricted Stock Unit Awards (RSUs) - Market conditions vesting-based:Number of
Units		Weighted
Average
Grant Date Fair
Value
 (in thousands) 
Unvested as of December 31, 20251,728 $2.55 
Granted— — 
Vested— — 
Forfeited— — 
Unvested as of March 31, 20261,728 $2.55 
Expected to vest as of March 31, 20261,661 $2.54 
Stock Option Awards:Number of
Options		Weighted Average
Exercise Price
 (in thousands)
Outstanding as of December 31, 20256,558 $5.59 
Granted946 4.29 
Exercised(1)0.88 
Forfeited/Expired(1)3.84 
Outstanding as of March 31, 20267,502 $5.42 
Expected to vest as of March 31, 20267,342 $5.45 
Exercisable as of March 31, 20265,441 $5.96 
Schedule of Stock Option Valuation Assumptions
The Company’s estimates of the fair value of the 2025 market conditions vesting-based awards at their grant or valuation dates were based on a Monte Carlo simulation and considered various variables and the following assumptions:
 Three Months Ended
March 31, 2025
Expected dividend yield0%
Expected volatility91.5%
Risk-free interest rate3.9%
Stock price at grant date
$2.65
The fair values of stock options granted were estimated using the Black-Scholes pricing model based on the following assumptions:
Three Months Ended
March 31, 2026
Expected dividend yield—%
Expected volatility98%
Expected term (years)6.1
Risk-free interest rate3.8%